AstraZeneca Olapale film has completed review approval for domestic listing application
-
Last Update: 2020-06-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recent days, AstraZeneca(Olaparis), has completed the review and approval of domestic listing applications, is expected to be approved for listingJanuary 2018, AstraZeneca Olapale tablets were included in the 26th batch of CDE to be included in the priority review process
the Drug(the public list of registration applications, and since then, AstraPaly film signed into the "fast lane" for listing approval, citing "significant therapeutic advantages over existing treatment methods"it is understood that global SALES of PARP inhibitors in 2017 were $462 million, of which Orapani alone contributed $297 million, accounting for more than halfso far, there are three types of PARP inhibitors approved worldwide, in addition to AstraZeneca's Orapari, Clovisy's Luca Pari and TESARO and Mercado's NirapaniBut so far, Nikapari and Nirapani have not filed for a registration and listing in Chinain addition,, there are currently 8 localpharmaceutical(enterprise(theof itsin the study of PARP inhibitors(approved domestic clinicaltest
(including Baiji Shenzhou, Reding
pharmaceutical (including Jiangsu Haosen, Qingfeng Pharmaceuticals, Renfu Pharmaceuticals, Hengrui Pharmaceuticals, Shanghai Tsingno Pharmaceuticals, and the Shanghai Pharmaceutical of the Chinese Academy of Sciences
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
